NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
18.21
-0.28 (-1.51%)
At close: Jun 18, 2025, 3:59 PM
18.20
-0.08%
After-hours: Jun 18, 2025, 04:33 PM EDT
-1.51% (1D)
| Bid | 18 |
| Market Cap | 2.05B |
| Revenue (ttm) | 47.14M |
| Net Income (ttm) | -187.36M |
| EPS (ttm) | -1.84 |
| PE Ratio (ttm) | -9.9 |
| Forward PE | -9.92 |
| Analyst | Buy |
| Ask | 21.15 |
| Volume | 440,502 |
| Avg. Volume (20D) | 913,415 |
| Open | 18.43 |
| Previous Close | 18.49 |
| Day's Range | 18.01 - 18.93 |
| 52-Week Range | 14.06 - 27.29 |
| Beta | -0.03 |
About NAMS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NAMS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NAMS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+0.1%
NAMS stock has given up its prior gain. NewAmsterd...
Unlock content with
Pro Subscription
1 week ago
+0.1%
NewAmsterdam Pharma shares are trading higher after the company announced topline data from prespecified Alzheimer's Disease biomarker analyses in the Phase 3 BROADWAY clinical trial
